Glutathione Impacts Both Batrachochytrium dendrobatidis Virulence and Amphibian Cellular Defense in a Chytridiomycosis Model
MicrobiologyOpen · 2026-04 · 15 (2)
DOI: 10.1002/mbo3.70271 ↗Kurz gefasst
Fachartikel in der Zeitschrift MicrobiologyOpen, online erschienen am 19.03.2026. Verfasst von Rebecca J Webb und 4 weiteren Autor:innen. Beteiligte Einrichtung: One Health Research Group, University of Melbourne, Melbourne, Australia. Hauptthemen laut MEDLINE: Glutathione, Batrachochytrium, Mycoses, Amphibians. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society of Queensland, University of Melbourne, Walter Fisher Grant for Mycology Research.
Abstract (Originalsprache)
Glutathione has important roles in diverse infections, yet its involvement in the interaction between the deadly fungal pathogen Batrachochytrium dendrobatidis ( Bd ) and its amphibian hosts is still unclear. Using in vitro assays and a cell infection model, we examined how glutathione influences Bd virulence traits and cellular host disease resistance. For Bd , inhibition of glutathione reductase rapidly killed zoospores, indicating that glutathione is essential for this pathogen. In addition, exposure to exogenous glutathione promoted the potential for virulence through accelerated and increased zoospore release. In host amphibian cells, Bd infection decreased intracellular glutathione content and increased reactive oxygen species, suggesting that chytridiomycosis pathogenesis involves oxidative stress. Depletion of host glutathione before exposure to Bd increased infection severity, whereas amphibian cells with slightly elevated glutathione levels were partially protected against Bd . However, manipulation of host glutathione levels after the establishment of Bd infection did not impact its intracellular growth, implying that the host glutathione‐mediated resistance only occurs during the initial Bd invasion process. Importantly, this effect of glutathione on host resistance is not a general response to pathogens, as it was not observed in cells exposed to the viral pathogen FV3. As glutathione increased both infectious zoospore production and host resistance to zoospore infection, our study suggests that this antioxidant may play an important role in the host/pathogen interaction during chytridiomycosis. Thus, environmental conditions and therapeutic approaches that affect glutathione systems in the host and/or pathogen have the potential to alter chytridiomycosis dynamics and should be further explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- One Health Research Group, University of Melbourne, Melbourne, Australia.
- Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
- Canberra Health Services, Garran, Australian Capital Territory, Australia.
ORCID-Profile: Rebecca J Webb
Förderung
- Royal Society of Queensland
- University of Melbourne
- Walter Fisher Grant for Mycology Research
- Morris Animal Foundation
- Australian Research Council
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Webb, R. J., Roberts, A. A., Berger, L., Robert, J., & Skerratt, L. F. (2026). Glutathione Impacts Both Batrachochytrium dendrobatidis Virulence and Amphibian Cellular Defense in a Chytridiomycosis Model. MicrobiologyOpen, 15(2). https://doi.org/10.1002/mbo3.70271
Vancouver
Webb RJ, Roberts AA, Berger L, Robert J, Skerratt LF. Glutathione Impacts Both Batrachochytrium dendrobatidis Virulence and Amphibian Cellular Defense in a Chytridiomycosis Model. MicrobiologyOpen. 2026;15(2). doi:10.1002/mbo3.70271
BibTeX
@article{Webb2026,
author = {Webb, Rebecca J and Roberts, Alexandra A and Berger, Lee and Robert, Jacques and Skerratt, Lee F},
title = {Glutathione Impacts Both Batrachochytrium dendrobatidis Virulence and Amphibian Cellular Defense in a Chytridiomycosis Model},
journal = {MicrobiologyOpen},
year = {2026},
volume = {15},
number = {2},
doi = {10.1002/mbo3.70271}
}
EUVIMED